Role of p53 up-regulated modulator of apoptosis in gemcitabine-induced apoptosis of human pancreatic cancer cell lines
Yan Ming-zong, Kejun Zhang, Tao Huang
Abstract
Yan Ming-zong, Kejun Zhang, Tao Huang
Abstract
Objective:To investigate the effect of gemcitabine on the proliferation of human pancreatic cancer AsPC-1 cells in vitro and elucidate the mechanism.Methods:The vector of antisense oligoneucleotides of p53 up-regulated modulator of apoptosis (PUMA) pcDNA3.1-PUMMAS and empty vector pcDNA3.1 was transfected into AsPC-1 cells by lipofectAMINE 2000 mediation,respectively. The stable clone was selected by G418. pcDNA3.1-PUMAAS-transfected,pcDNA3.1-transfected,and control AsPC-1 cells were treated with serial concentrations(1,5,10,and 15 μmol/L)of gemcitabine for 72 h.The expressions of PUMA mRNA and protein were detected by RT-PCR and Western blotting.MTT assay was used to measure the inhibitory actions of gemcitabine on AsPC-1 cells.The apoptosis was detected by flow cytometry,Hoechst 33258 staining,and TUNEL staining.Results:Gemcitabine induced apoptosis of AsPC-1 cells and inhibited the proliferation in a dose-dependent manner. The apoptosis induced by gemcitabine was accompanied with the up-regulation of PUMA. In pcDNA3.1-PUMAAS-transfected cells,the up-regulation of PUMA induced by gemcitabine was significantly decreased compared with AsPC-1 control cells and pcDNA3.1 transfected cells.The apoptosis was inhibited and the proliferation was increased after transfection of pcDNA3.1-PUMAAS.Conclusion:Gemcitabine induced the apoptosis of AsPC-1 cells and inhibited the proliferation in vitro. The apoptosis-inducing effect was related to up-regulation of PUMA expression.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effect of gemcitabine on the proliferation of human pancreatic cancer AsPC-1 cells in vitro and elucidate the mechanism.Methods:The vector of antisense oligoneucleotides of p53 up-regulated modulator of apoptosis (PUMA) pcDNA3.1-PUMMAS and empty vector pcDNA3.1 was transfected into AsPC-1 cells by lipofectAMINE 2000 mediation,respectively. The stable clone was selected by G418. pcDNA3.1-PUMAAS-transfected,pcDNA3.1-transfected,and control AsPC-1 cells were treated with serial concentrations(1,5,10,and 15 μmol/L)of gemcitabine for 72 h.The expressions of PUMA mRNA and protein were detected by RT-PCR and Western blotting.MTT assay was used to measure the inhibitory actions of gemcitabine on AsPC-1 cells.The apoptosis was detected by flow cytometry,Hoechst 33258 staining,and TUNEL staining.Results:Gemcitabine induced apoptosis of AsPC-1 cells and inhibited the proliferation in a dose-dependent manner. The apoptosis induced by gemcitabine was accompanied with the up-regulation of PUMA. In pcDNA3.1-PUMAAS-transfected cells,the up-regulation of PUMA induced by gemcitabine was significantly decreased compared with AsPC-1 control cells and pcDNA3.1 transfected cells.The apoptosis was inhibited and the proliferation was increased after transfection of pcDNA3.1-PUMAAS.Conclusion:Gemcitabine induced the apoptosis of AsPC-1 cells and inhibited the proliferation in vitro. The apoptosis-inducing effect was related to up-regulation of PUMA expression.
Key concepts: Gemcitabine, Apoptosis, Transfection, Lipofectamine, Puma, Flow cytometry, MTT assay, Molecular biology